The geko™ device now in routine use across multiple UK NHS hospitals and internationally. HIGH WYCOMBE, England, Feb. 14, 2020 /PRNewswire/ -- Firstkind Ltd, a UK-based medical devices company and ...

The sponsor submitted a de novo cost analysis using a decision tree model that estimated the cost associated with the geko device compared with no mechanical prophylaxis. The model population was ...

- Clinical trial shows patients prescribed the geko™ device experienced shortened hospital stays by more than one day after a kidney transplant - The device reduced surgical site infections by almost ...

The National Institute for Health and Care Excellence (NICE) has opened a consultation on draft medical technology guidance on a device designed to reduce the risk of venous thromboembolism (VTE) in a ...

Sky Medical Technology Ltd. has cinched FDA clearance for a third indication for its geko device, a noninvasive, battery-powered wearable technology designed to increase blood flow in the deep veins ...

In a published study, a team from Lawson Health Research Institute has found that a simple device can reduce swelling after kidney transplantation. The geko™ device, manufactured by Sky Medical ...

Patients who are recovering from a stroke are vulnerable to potentially fatal blood clots, known as venous thromboembolism or VTE. Fortunately, medical experts have discovered a tool that helps keep ...

DARESBURY, England, March 25, 2022 /PRNewswire/ --Sky Medical Technology Ltd (Sky) has today announced it has achieved further U.S. Food and Drug Administration (FDA) 510(k) clearance to market the ...

The geko device (FirstKind Ltd) is a battery powered, disposable neuromuscular electrostimulation device that is designed to increase venous blood flow, with the aim of reducing the risk of venous ...

LONDON, ON - In a published study, a team from Lawson Health Research Institute has found that a simple device can reduce swelling after kidney transplantation. The geko™ device, manufactured by Sky ...